21
Participants
Start Date
July 24, 2023
Primary Completion Date
December 31, 2030
Study Completion Date
December 31, 2030
Afimkibart
Afimkibart will be administered during the Induction, Maintenance and OLE period.
AZ Delta, Roeselare
I.H.S Health Northwell Health, Kissimmee
Digestive Health Specialists, Dothan
CHU de Nantes, Nantes
Clinical Research Institute of Michigan, Chesterfield
CHRU de Nancy Brabois, Vandœuvre-lès-Nancy
Institut des MICI, Clinique Ambroise Paré, Neuilly-sur-Seine
Medical Research Center of Connecticut, LLC, Hamden
Brigham and Women's Hospital, Boston
Twoja Przychodnia-Szczecinskie Centrum Medyczne, Szczecin
WIP Warsaw IBD Point Profesor Kierkus, Warsaw
Hoffmann-La Roche
INDUSTRY